13-HYDROXYMYCINAMICIN DERIVATIVE
NEW MATERIAL:A compound shown by the formulaI(A is a group shown by the formula II when R is H, a group shown by the formula III when R is OH, and a group shown by the formula IV when R is a group constituting 11,14- epoxy group; Q is a group constituting 11,14-epoxy). EXAMPLE:12,13-Deepoxy-13-hydro...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | NEW MATERIAL:A compound shown by the formulaI(A is a group shown by the formula II when R is H, a group shown by the formula III when R is OH, and a group shown by the formula IV when R is a group constituting 11,14- epoxy group; Q is a group constituting 11,14-epoxy). EXAMPLE:12,13-Deepoxy-13-hydroxymycinamicinI. USE:An oral or injection remedy for infectious deseases caused by Gram-positive bacteria or mycoplasm or an animal growth promotor. PROCESS:(A) Mycinamicin(MMN)Ior MMN II is reacted with an electron donor metal (e.g., zinc powder, etc.) and an ammonium salt (e.g., NH4Cl, etc.) in a hydrous polar solvent (e.g., water/tetrahydrofuran, etc.) or (B) a culture of a bacterium (e.g., Streptomyces variabilis TYJ-689, etc.) capable of converting MMNIor MMN II to the desired substance, its mold, or treated materials thereof are reacted with MMNIor MMN II in an aqueous medium in the absence of O2, to give a compound shown by the formulaI. |
---|